News

News

The American College of Cardiology and the American Heart Association today released a revised guideline for minimizing the risk of cardiovascular complications around the time of...

August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter...

August 27, 2014 — The Society of Cardiovascular Computed Tomography (SCCT) has published the “SCCT Guidelines on the Use of Coronary Computed Tomographic Angiography for Patients Presenting with...

Hemostasis Biolife StatSeal Advanced Disc Cath Lab

Cath Labs, interventional radiology suites and hospitals are continually trying to improve patient comfort as well as save time and reduce costs. With these goals in mind, Biolife introduces...

FDA Fysicon DataLinQ Pacemaker Programmer Acquisition Device

Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable complete automation.

August 26, 2014 — Toshiba America Medical Systems’ MR (magnetic resonance) systems have received approval to operate (ATO) with the U.S. Air Force. This makes Toshiba the only manufacturer to have...

August 26, 2014 — The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes,...

The mantra for treatment for high blood pressure has been "the lower, the better," but that goal can potentially put patients at risk of kidney failure or death, according to a Kaiser Permanente...

Columbia University Univ. South Florida Clinical Trial Therapy Artery Repair

A new therapy developed by researchers at the University of South Florida (USF) Morsani College of Medicine and Columbia University Medical Center (CUMC) may help reduce the life-threatening...

Esaote MyLab Six Flexible Enhanced Ultrasound ESC

Esaote is launching MyLab Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology) in Barcelona, to be held Aug. 30 to Sept. 3. Configured for...

New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest...

Esaote MyLab Gamma Cardiovascular Ultrasound System

Esaote is launching MyLab Gamma, a best-in-class, highly portable “green” cardiovascular ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, Aug. 30-Sept. 3). 

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of...

Biotronik announced the first implantations worldwide of its new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators).

Sunshine Heart's C-Pulse System Heart Failure Treatment

Sunshine Heart Inc. announced that the current condition of a heart failure patient implanted with the C-Pulse System improved after six weeks of treatment, allowing him to attend his daughter's...

August 21, 2014 — Christie Medical Holdings and Wolfson Children’s Hospital announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17...

August 21, 2014 — diaDexus announced it has received notice from the U.S. Food and Drug Administration (FDA) that an administrative acceptance review was conducted on the traditional 510(k)...

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop...

August 21, 2014 — Corindus Vascular Robotics announced the results of a retrospective study comparing use of radiation and contrast for patients enrolled in its CorPath PRECISE (Percutaneous...

Cedars-Sinai Heart Institute Clinic Heart Vascular Disease Stem Cell Studies

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.